Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

SHE:000623 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,215	1,107	1,720	1,438	1,743	2,504
Short-Term Investments	-	-	-	788	704	709
Trading Asset Securities	1,894	1,568	1,658	1,640	2,189	1,300
Cash & Short-Term Investments	3,109	2,675	3,378	3,866	4,635	4,513
Cash Growth	4.81%	-20.81%	-12.62%	-16.59%	2.71%	-1.66%
Accounts Receivable	992.95	1,157	1,407	1,056	964.31	951.03
Other Receivables	182.59	23.18	29.98	60.31	68.53	83.35
Receivables	1,176	1,181	1,437	1,116	1,033	1,034
Inventory	879.19	936.9	872.35	874.57	591.88	548.45
Prepaid Expenses	-	-	-	-	0.16	0.01
Other Current Assets	55.52	40.41	57.55	124.69	65.59	87.41
Total Current Assets	5,220	4,833	5,745	5,982	6,326	6,183
Property, Plant & Equipment	2,475	2,558	2,534	2,339	2,296	2,246
Long-Term Investments	26,007	24,647	23,003	21,891	19,637	18,283
Other Intangible Assets	453.96	437.32	435.35	365.08	359.61	329.44
Long-Term Deferred Tax Assets	251.28	326.23	309.84	303.12	164.27	118.52
Long-Term Deferred Charges	82.86	111.57	163.96	212.25	188.02	126.37
Other Long-Term Assets	86.11	88.33	75.77	89.83	96.53	67.6
Total Assets	34,576	33,002	32,266	31,182	29,067	27,353
Accounts Payable	360.65	425.71	418.59	450.97	238.22	262.56
Accrued Expenses	46.29	106.87	148.94	183.15	111.71	107.5
Short-Term Debt	1,142	1,255	678.31	651.27	355.52	373.38
Current Portion of Long-Term Debt	-	-	2,315	-	-	-
Current Portion of Leases	12.63	22.48	17.88	18.23	25.41	-
Current Income Taxes Payable	26.17	5.9	28.28	11.52	19.31	9.21
Current Unearned Revenue	29.09	34.69	26.26	82.25	18.36	19.95
Other Current Liabilities	820.19	613.31	834.8	817.97	687.19	611.45
Total Current Liabilities	2,437	2,464	4,468	2,215	1,456	1,384
Long-Term Debt	1,087	995.22	-	2,303	2,211	2,108
Long-Term Leases	5.5	16.51	21.49	17.55	23.38	-
Long-Term Unearned Revenue	215.26	223.87	247.38	281.6	313.86	321.31
Long-Term Deferred Tax Liabilities	14.1	20.17	30.03	26.06	24.21	9.9
Other Long-Term Liabilities	-	-	-	-	-	0.5
Total Liabilities	3,759	3,720	4,767	4,844	4,029	3,824
Common Stock	1,196	1,196	1,168	1,163	1,163	1,163
Additional Paid-In Capital	4,897	4,852	4,035	3,947	3,980	3,965
Retained Earnings	24,140	22,466	21,871	20,741	19,243	17,690
Treasury Stock	-420.01	-300	-720.07	-570.07	-400.03	-300.03
Comprehensive Income & Other	754.5	814.1	856.99	753.71	873.11	834.39
Total Common Equity	30,568	29,028	27,212	26,034	24,859	23,353
Minority Interest	249.03	254.65	288.01	303.54	179.26	176.26
Shareholders' Equity	30,817	29,282	27,500	26,338	25,039	23,529
Total Liabilities & Equity	34,576	33,002	32,266	31,182	29,067	27,353
Total Debt	2,247	2,289	3,032	2,990	2,616	2,482
Net Cash (Debt)	862.39	385.96	346.02	875.84	2,020	2,031
Net Cash Growth	9.36%	11.54%	-60.49%	-56.63%	-0.57%	-18.61%
Net Cash Per Share	0.73	0.33	0.27	0.67	1.60	1.59
Filing Date Shares Outstanding	1,172	1,172	1,123	1,127	1,139	1,139
Total Common Shares Outstanding	1,172	1,180	1,123	1,127	1,139	1,145
Working Capital	2,782	2,369	1,277	3,767	4,870	4,799
Book Value Per Share	26.07	24.61	24.23	23.10	21.83	20.39
Tangible Book Value	30,114	28,590	26,776	25,669	24,500	23,024
Tangible Book Value Per Share	25.69	24.24	23.84	22.78	21.51	20.11
Buildings	-	2,287	2,202	2,138	2,039	1,991
Machinery	-	1,512	1,491	1,413	1,321	1,265
Construction In Progress	-	424.87	349.54	177.36	179.32	133

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.